COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 36

Article download: 27

IP Journal of Diagnostic Pathology and Oncology


Comparative Analysis of “ Screening vs Modified ” APTT based activated protein C resistance (APCR) assay in the diagnosis of Factor V leiden mutation


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Mirza Asif Baig*

Volume : 5, Issue : 1, Year : 2020

Article Page : 48-52


Suggest article by email

Abstract

Introduction: APCR is a hemostatic disorder characterized by increased risk of deep vein thrombosis and
pulmonary embolism. Factor V Leiden mutation accounts for 95% of APCR cases & the remainder are due
to acquired causes like patients on vitamin k antagonist therapy, direct oral acting anticoagulants, Lupus
anticoagulant & oral contraceptive pills. T he main objective of this study is to compare the sensitivity of
APTT based APCR test vs Modified APTT with pre -dilution in F actor V-deficient plasma for diagnosis
of Factor V leiden mutation & to formulate a systematic diagnostic algorithm for interpretation of APCR
tests.
Materials and Methods: The Coagulometer used for APCR test is Sysmex CS-5100. APTT reagent used
is Pathrombin SL supplied by seimens. All data were expressed as Mean SD. Statistical analysis was
done using unpaired students t test & a P value <0> Results: A total of 150 cases of APCR (100 cases of factor V Leiden mutation confirmed by PCR &
50 non carrier /acquired cases) were studied retrospectively. Sensitivity of screening APTT base d APCR
for detection of factor V Leiden mutation is 78% & for non carrier state it is 82%. Sensitivity of modified
APTT with pre- dilution in FV-deficient plasmafor detection of factor V Leiden mutation is 93% & for
noncarrier state (acquired) is 34%.
Conclusion: Screening APTT test is increased in Activated protein C resistance due to factor V Leiden
mutation as well as acquired causes like patients on direct acting oral anticoagulants, warfarin, lupus
anticoagulants and oral contraceptive pills which are independent risk factors of venous thrombosis.
Modified APTT with predilution in FV-deficient plasma (1:4) is more sensitive than Screening APTT based
APCR test in diagnosis of Factor VLeiden mutation&this test can distinguish homozygous&heterozygous
states from normal individuals.

Keywords: APTT, Activated Protein C resistance factor V Leiden mutation LAC

Doi : 10.18231/j.jdpo.2020.010

How to cite : Baig M A, Comparative Analysis of “ Screening vs Modified ” APTT based activated protein C resistance (APCR) assay in the diagnosis of Factor V leiden mutation. IP J Diagn Pathol Oncol 2020;5(1):48-52

Copyright © 2020 by author(s) and IP J Diagn Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)